BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27423865)

  • 1. Synthesis and Assays of Inhibitors of Methyltransferases.
    Cai XC; Kapilashrami K; Luo M
    Methods Enzymol; 2016; 574():245-308. PubMed ID: 27423865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of analogues of S-adenosyl-L-methionine, as inhibitors of the E. coli cyclopropane fatty acid synthase.
    Guérard C; Bréard M; Courtois F; Drujon T; Ploux O
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1661-4. PubMed ID: 15026045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.
    Barral K; Sallamand C; Petzold C; Coutard B; Collet A; Thillier Y; Zimmermann J; Vasseur JJ; Canard B; Rohayem J; Debart F; Decroly E
    Antiviral Res; 2013 Sep; 99(3):292-300. PubMed ID: 23769894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Assays for RNA Methyltransferase Activity.
    Haag S; Sloan KE; Höbartner C; Bohnsack MT
    Methods Mol Biol; 2017; 1562():259-268. PubMed ID: 28349466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A direct label-free MALDI-TOF mass spectrometry based assay for the characterization of inhibitors of protein lysine methyltransferases.
    Guitot K; Drujon T; Burlina F; Sagan S; Beaupierre S; Pamlard O; Dodd RH; Guillou C; Bolbach G; Sachon E; Guianvarc'h D
    Anal Bioanal Chem; 2017 Jun; 409(15):3767-3777. PubMed ID: 28389916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N
    Zhong W; Koay A; Ngo A; Li Y; Nah Q; Wong YH; Chionh YH; Ng HQ; Koh-Stenta X; Poulsen A; Foo K; McBee M; Choong ML; El Sahili A; Kang C; Matter A; Lescar J; Hill J; Dedon P
    ACS Infect Dis; 2019 Mar; 5(3):326-335. PubMed ID: 30682246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
    Anglin JL; Deng L; Yao Y; Cai G; Liu Z; Jiang H; Cheng G; Chen P; Dong S; Song Y
    J Med Chem; 2012 Sep; 55(18):8066-74. PubMed ID: 22924785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibitors of protein methyltransferases.
    Kaniskan HÜ; Konze KD; Jin J
    J Med Chem; 2015 Feb; 58(4):1596-629. PubMed ID: 25406853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic Writer.
    Bedi RK; Huang D; Eberle SA; Wiedmer L; Śledź P; Caflisch A
    ChemMedChem; 2020 May; 15(9):744-748. PubMed ID: 32159918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel DNA methyltransferase 3A inhibitors via structure-based virtual screening and biological assays.
    Shao Z; Xu P; Xu W; Li L; Liu S; Zhang R; Liu YC; Zhang C; Chen S; Luo C
    Bioorg Med Chem Lett; 2017 Jan; 27(2):342-346. PubMed ID: 27899265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new inhibitors of E. coli cyclopropane fatty acid synthase using a colorimetric assay.
    Guianvarc'h D; Drujon T; Leang TE; Courtois F; Ploux O
    Biochim Biophys Acta; 2006 Aug; 1764(8):1381-8. PubMed ID: 16872920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of inhibitors of the E. coli cyclopropane fatty acid synthase from the screening of a chemical library: In vitro and in vivo studies.
    Guianvarc'h D; Guangqi E ; Drujon T; Rey C; Wang Q; Ploux O
    Biochim Biophys Acta; 2008 Nov; 1784(11):1652-8. PubMed ID: 18501724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical Biology Approaches for Characterization of Epigenetic Regulators.
    Barsyte-Lovejoy D; Szewczyk MM; Prinos P; Lima-Fernandes E; Ackloo S; Arrowsmith CH
    Methods Enzymol; 2016; 574():79-103. PubMed ID: 27423858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases.
    Zhang J; Zheng YG
    ACS Chem Biol; 2016 Mar; 11(3):583-97. PubMed ID: 26540123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development.
    Rogawski DS; Grembecka J; Cierpicki T
    Future Med Chem; 2016 Sep; 8(13):1589-607. PubMed ID: 27548565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyltransferase-Glo: a universal, bioluminescent and homogenous assay for monitoring all classes of methyltransferases.
    Hsiao K; Zegzouti H; Goueli SA
    Epigenomics; 2016 Mar; 8(3):321-39. PubMed ID: 26950288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of methyltransferases and other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry (CCMS).
    Lenz T; Poot P; Gräbner O; Glinski M; Weinhold E; Dreger M; Köster H
    J Vis Exp; 2010 Dec; (46):. PubMed ID: 21189471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOT1L) Inhibitors using a Target-Specific Scoring Function for the (S)-Adenosyl-l-methionine (SAM)-Dependent Methyltransferase Family.
    Wang Y; Li L; Zhang B; Xing J; Chen S; Wan W; Song Y; Jiang H; Jiang H; Luo C; Zheng M
    J Med Chem; 2017 Mar; 60(5):2026-2036. PubMed ID: 28165739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes.
    Drake KM; Watson VG; Kisielewski A; Glynn R; Napper AD
    Assay Drug Dev Technol; 2014 Jun; 12(5):258-71. PubMed ID: 24927133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of adenosine-based ligands to the MjDim1 rRNA methyltransferase: implications for reaction mechanism and drug design.
    O'Farrell HC; Musayev FN; Scarsdale JN; Rife JP
    Biochemistry; 2010 Mar; 49(12):2697-704. PubMed ID: 20163168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.